BlackRock, Inc. (BLK) 13D/13G Filings for PTC Therapeutics, Inc. (PTCT)

BlackRock, Inc. 13D and 13G filings for PTC Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2025-04-17
09:35 am
Sale
2025-03-31 13G PTC Therapeutics, Inc.
PTCT
BLACKROCK INC
BLK
6,274,384
8.000%
-1,394,487decrease
(-18.18%)
Filing
2024-01-08
4:35 pm
Purchase
2023-12-31 13G PTC Therapeutics, Inc.
PTCT
BLACKROCK INC
BLK
7,668,871
10.200%
1,028,017increase
(+15.48%)
Filing
2023-01-24
1:56 pm
Purchase
2022-12-31 13G PTC Therapeutics, Inc.
PTCT
BLACKROCK INC
BLK
6,640,854
9.200%
250,913increase
(+3.93%)
Filing
2022-02-02
7:11 pm
Purchase
2021-12-31 13G PTC Therapeutics, Inc.
PTCT
BLACKROCK INC
BLK
6,389,941
9.000%
361,822increase
(+6.00%)
Filing
2021-01-29
5:22 pm
Purchase
2020-12-31 13G PTC Therapeutics, Inc.
PTCT
BLACKROCK INC
BLK
6,028,119
8.800%
1,113,526increase
(+22.66%)
Filing